David Pittman of Medpagetoday.com reports that the Institute of Medicine (IOM) applauded the NIH’s Clinical and Translational Science Awards (CTSA) Program and its significance to the advancement of clinical and translational research. The CTSA program was created to provide research support, infrastructure, and training to move basic science to clinical trials.  With a budget of $461 million, grants are usually 5 years long and can span anywhere between $4 and $23 million. The IOM conducted a review over the CTSA program and found them to have made progress in reshaping clinical and translational research, also finding their growth from 12 to 61 sites as an opportunity of a strong national network. The IOM states that the next step for the CTSA and NIH is to integrate the work that it funds. A possible “CTSA 2.0” that can set creative goals for the national network that establishes collaboration inside and outside their home institutions.  To read the full article click here.